neflamapimod

EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate
CP Wire
Wed, 05/16/18 - 09:13 am
EIP Pharma
Alzheimer's disease
neflamapimod
EIP Pharma Receives $20.5 Million Series B to Fund Alzheimer's Candidate
Wed, 05/16/18 - 07:55 am
EIP Pharma
Alzheimer's disease
neflamapimod